2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Cervical cancer

2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis

Free

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	23	0	2
Nov 2022	36	0	3
Dec 2022	57	0	8
Jan 2023	19	0	2
Feb 2023	13	0	2
Mar 2023	16	0	1
Apr 2023	22	0	2
May 2023	16	0	1
Jun 2023	4	0	1
Jul 2023	14	0	5
Aug 2023	18	0	9
Sep 2023	17	0	3
Oct 2023	23	0	5
Nov 2023	12	0	2
Dec 2023	20	0	2
Jan 2024	44	0	1
Feb 2024	24	0	1
Mar 2024	11	0	2
Apr 2024	6	0	2
Total	395	0	54